OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zining Zhang, Heng Zhang, Xiang Liao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
Zining Zhang, Heng Zhang, Xiang Liao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Oral bacteria accelerate pancreatic cancer development in mice
Elias S. Saba, Maria Farhat, Alaa Daoud, et al.
Gut (2024) Vol. 73, Iss. 5, pp. 770-786
Closed Access | Times Cited: 23
Elias S. Saba, Maria Farhat, Alaa Daoud, et al.
Gut (2024) Vol. 73, Iss. 5, pp. 770-786
Closed Access | Times Cited: 23
Dynamic Coupling of MAPK Signaling to the Guanine Nucleotide Exchange Factor GEF-H1
Kévin Leguay, Oliver A. Kent
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 147-159
Open Access | Times Cited: 1
Kévin Leguay, Oliver A. Kent
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 147-159
Open Access | Times Cited: 1
Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai
Cells (2024) Vol. 13, Iss. 7, pp. 602-602
Open Access | Times Cited: 7
Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai
Cells (2024) Vol. 13, Iss. 7, pp. 602-602
Open Access | Times Cited: 7
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 5
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 5
Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
Szu-Aun Long, Amber M. Amparo, Grace Goodhart, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Szu-Aun Long, Amber M. Amparo, Grace Goodhart, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Fast-Relaxing Hydrogels Promote Pancreatic Adenocarcinoma Cell Aggressiveness through Integrin β1 Signaling
Han Nguyen, Ngoc Ha Luong, Jacqueline Peil, et al.
Biomacromolecules (2025)
Closed Access
Han Nguyen, Ngoc Ha Luong, Jacqueline Peil, et al.
Biomacromolecules (2025)
Closed Access
Recent Anti-KRASG12D Therapies: A “Possible Impossibility” for Pancreatic Ductal Adenocarcinoma
Navid Sobhani, Matteo Pittacolo, Alberto D’Angelo, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 704-704
Open Access
Navid Sobhani, Matteo Pittacolo, Alberto D’Angelo, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 704-704
Open Access
Characteristics of KRAS gene mutations in real clinical practice for pancreatic cancer
Mariam Sh. Manukian, I. Bazin, А. А. Tryakin
Surgery and Oncology (2025) Vol. 15, Iss. 1, pp. 28-35
Closed Access
Mariam Sh. Manukian, I. Bazin, А. А. Tryakin
Surgery and Oncology (2025) Vol. 15, Iss. 1, pp. 28-35
Closed Access
Copper-KRAS-COX2 Axis: A Therapeutic Vulnerability in Pancreatic Cancer
Joyeeta Roy, Rima Mouawad, Armita Kyani, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Joyeeta Roy, Rima Mouawad, Armita Kyani, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Quantitative characterization of the 3D self-organization of PDAC tumor spheroids reveals cell type and matrix dependence through advanced microscopy analysis
Soraya Hernández-Hatibi, Carlos Borau, Neus Martínez‐Bosch, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access
Soraya Hernández-Hatibi, Carlos Borau, Neus Martínez‐Bosch, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access
Identification of key hub genes in pancreatic ductal adenocarcinoma: an integrative bioinformatics study
Kankana Bhattacharjee, Avik Sengupta, Rahul Kumar, et al.
Frontiers in Bioinformatics (2025) Vol. 5
Open Access
Kankana Bhattacharjee, Avik Sengupta, Rahul Kumar, et al.
Frontiers in Bioinformatics (2025) Vol. 5
Open Access
Correlation of MRI characteristics with KRAS mutation status in pancreatic ductal adenocarcinoma
Junjian Shen, Xingxing Wang, Kaifan Yu, et al.
Abdominal Radiology (2025)
Closed Access
Junjian Shen, Xingxing Wang, Kaifan Yu, et al.
Abdominal Radiology (2025)
Closed Access
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
Maria Victoria García‐Ortiz, Pablo Cano-Ramírez, Marta Toledano‐Fonseca, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Maria Victoria García‐Ortiz, Pablo Cano-Ramírez, Marta Toledano‐Fonseca, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Pancreatic Cancer and Venous Thromboembolism
Teagan Prouse, Mohammad A. Mohammad, Sonali Ghosh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5661-5661
Open Access | Times Cited: 4
Teagan Prouse, Mohammad A. Mohammad, Sonali Ghosh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5661-5661
Open Access | Times Cited: 4
Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy
Fikriye Ozgencil, Habibe Beyza Gunindi, Gökçen Eren
Bioorganic Chemistry (2024) Vol. 149, pp. 107509-107509
Closed Access | Times Cited: 3
Fikriye Ozgencil, Habibe Beyza Gunindi, Gökçen Eren
Bioorganic Chemistry (2024) Vol. 149, pp. 107509-107509
Closed Access | Times Cited: 3
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors
Ana M. López-Estévez, Lucía Sanjurjo, Ángela Turrero, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 277-292
Open Access | Times Cited: 2
Ana M. López-Estévez, Lucía Sanjurjo, Ángela Turrero, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 277-292
Open Access | Times Cited: 2
SLB-msSIM: a spectral library-based multiplex segmented SIM platform for single-cell proteomic analysis
Lakmini Senavirathna, Cheng Ma, Vanessa Duong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Lakmini Senavirathna, Cheng Ma, Vanessa Duong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies
Tasvi Daya, Andrea Breytenbach, Liang Gu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2024) Vol. 1870, Iss. 2, pp. 159578-159578
Open Access | Times Cited: 2
Tasvi Daya, Andrea Breytenbach, Liang Gu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2024) Vol. 1870, Iss. 2, pp. 159578-159578
Open Access | Times Cited: 2
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 2
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 2
Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic Cancer
XUAN WANG, Judith Breuer, Stephan Garbe, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6249-6249
Open Access | Times Cited: 1
XUAN WANG, Judith Breuer, Stephan Garbe, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6249-6249
Open Access | Times Cited: 1
In Silico Identification of Dysregulated miRNAs Targeting KRAS Gene in Pancreatic Cancer
Asbiel Felipe Garibaldi-Ríos, Luis E. Figuera, Guillermo Moisés Zúñiga‐González, et al.
Diseases (2024) Vol. 12, Iss. 7, pp. 152-152
Open Access | Times Cited: 1
Asbiel Felipe Garibaldi-Ríos, Luis E. Figuera, Guillermo Moisés Zúñiga‐González, et al.
Diseases (2024) Vol. 12, Iss. 7, pp. 152-152
Open Access | Times Cited: 1
Genetics and biology of pancreatic ductal adenocarcinoma
Maung Jai, Paul Mozdziak
Medical Journal of Cell Biology (2024) Vol. 12, Iss. 2, pp. 42-47
Open Access
Maung Jai, Paul Mozdziak
Medical Journal of Cell Biology (2024) Vol. 12, Iss. 2, pp. 42-47
Open Access
Key Genes and Pathways in the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: A Bioinformatics and Machine Learning Study
Sinan Eyuboglu, Semih Alpsoy, Vladimir N. Uversky, et al.
Computational Biology and Chemistry (2024), pp. 108268-108268
Closed Access
Sinan Eyuboglu, Semih Alpsoy, Vladimir N. Uversky, et al.
Computational Biology and Chemistry (2024), pp. 108268-108268
Closed Access
The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7
Júber Herrera-Uribe, Orla Convery, Daniah Hameed Almohammadi, et al.
Inflammation (2024)
Closed Access
Júber Herrera-Uribe, Orla Convery, Daniah Hameed Almohammadi, et al.
Inflammation (2024)
Closed Access
